The agency’s decision on Monday sets up shots to be rolled out later this month.
The FDA on Monday cleared two updated mRNA Covid-19 shots from Pfizer-BioNTech, Moderna and Novavax, paving the way for an early fall rollout. It will be the first updated shots offered to the public in a year and since the public health emergency ended in May.
The new shots target the XBB.1.5 subvariant of Omicron, following the FDA’s June recommendation. Both companies said their shots generate substantial antibodies against the XBB subvariants of the virus, as well as the newer EG.5 and FL.
